|
Secondary prevention
Citations 111-120 of 568 total displayed.
|
Past content
(since Feb 1999):
|
-
;:
- Articles
Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden. Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy
- Leslee J. Shaw, Daniel S. Berman, David J. Maron, G. B. John Mancini, Sean W. Hayes, Pamela M. Hartigan, William S. Weintraub, Robert A. O’Rourke, Marcin Dada, John A. Spertus, Bernard R. Chaitman, John Friedman, Piotr Slomka, Gary V. Heller, Guido Germano, Gilbert Gosselin, Peter Berger, William J. Kostuk, Ronald G. Schwartz, Merill Knudtson, Emir Veledar, Eric R. Bates, Benjamin McCallister, Koon K. Teo, William E. Boden for the COURAGE Investigators
Circulation published February 11, 2008, doi:10.1161/CIRCULATIONAHA.107.743963
[Abstract]
- Controversies in Cardiovascular Medicine
Lipid Management to Reduce Cardiovascular Risk: A New Strategy Is Required
- H. Robert Superko and Spencer King, III
Circulation 2008;117:560-568, doi:10.1161/CIRCULATIONAHA.106.667428
[Full text]
- Articles
Oral Buflomedil in the Prevention of Cardiovascular Events in Patients With Peripheral Arterial Obstructive Disease. A Randomized, Placebo-Controlled, 4-Year Study
- Limbs International Medicinal Buflomedil (LIMB) Study Group and Alain Leizorovicz
Circulation published January 22, 2008, doi:10.1161/CIRCULATIONAHA.107.706374
[Abstract]
- Editorials
Using Computer-Based Decision Support to Close the "Know–Do" Gap in Lipid-Lowering Therapy
- Jerry Avorn and Niteesh K. Choudhry
Circulation 2008;117:336-337, doi:10.1161/CIRCULATIONAHA.107.745042
[Full text]
- Health Services and Outcomes Research
Electronic Alerts Versus On-Demand Decision Support to Improve Dyslipidemia Treatment: A Cluster Randomized Controlled Trial
- Jacobus T. van Wyk, Marc A.M. van Wijk, Miriam C.J.M. Sturkenboom, Mees Mosseveld, Peter W. Moorman, and Johan van der Lei
Circulation 2008;117:371-378; published online before print as doi:10.1161/CIRCULATIONAHA.107.697201
[Abstract]
[Full text]
- Vascular Medicine
Dietary  -Lipoic Acid Supplementation Inhibits Atherosclerotic Lesion Development in Apolipoprotein E–Deficient and Apolipoprotein E/Low-Density Lipoprotein Receptor–Deficient Mice
- Wei-Jian Zhang, Karyn E. Bird, Timothy S. McMillen, Renee C. LeBoeuf, Tory M. Hagen, and Balz Frei
Circulation 2008;117:421-428; published online before print as doi:10.1161/CIRCULATIONAHA.107.725275
[Abstract]
[Full text]
- Articles
Electronic Alerts Versus On-Demand Decision Support to Improve Dyslipidemia Treatment. A Cluster Randomized Controlled Trial
- Jacobus T. van Wyk, Marc A.M. van Wijk, Miriam C.J.M. Sturkenboom, Mees Mosseveld, Peter W. Moorman, and Johan van der Lei
Circulation published January 2, 2008, doi:10.1161/CIRCULATIONAHA.107.697201
[Abstract]
- Articles
Dietary -Lipoic Acid Supplementation Inhibits Atherosclerotic Lesion Development in Apolipoprotein E–Deficient and Apolipoprotein E/Low-Density Lipoprotein Receptor–Deficient Mice
- Wei-Jian Zhang, Karyn E. Bird, Timothy S. McMillen, Renee C. LeBoeuf, Tory M. Hagen, and Balz Frei
Circulation published December 24, 2007, doi:10.1161/CIRCULATIONAHA.107.725275
[Abstract]
- Corrections
Correction
-
Circulation 2007;116:e558, doi:10.1161/CIRCULATIONAHA.107.188274
[Full text]
|
|
